Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
Last Updated: Tuesday, April 12, 2022
Employing machine learning and data from the targeted transcriptome, researchers developed a model to stratify patients with DLBCL into four subgroups based on survival characteristics, in order to predict nonresponse to R-CHOP therapy.
Advertisement
News & Literature Highlights
